The Jury Is Still out on Ginkgo and Alzheimer's

buy microsoft office enterprise 2007

buy Microsoft Office 2003 Professional sp3buy autodesk autocad 2009

The Jury Is Still out on Ginkgo and Alzheimer's

The number of older individuals in the population of countries all over the world is increasing. Researchers and clinicians are understandably interested in discovering the most effective means for dealing with the many diseases associated with aging.

Alzheimer's disease (AD), which can be so devastating both to the patients and their families, is receiving widespread attention.
This review of the literature attempted to collect and summarize published research pertaining to the effect of Ginkgo biloba extract on cognitive function in patients with Alzheimer's.
Treatment with 120 to 240 mg of G biloba extract was found to have a small but significant effect on objective measures of cognitive function in AD patients. But the study concluded that far more research will be needed to provide conclusive evidence of the efficacy of Ginkgo for treating AD.
Given the less-than-convincing evidence of the current literature, it would not be advisable to unreservedly recommend Ginkgo as proven therapy for victims of Alzheimer's.
Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology, Nov. 1998;55(11), pp1409-15.